NanoenTekInc (039860.KQ) stock: key figures, P/E, revenue and dividend

Health Care · Life Sciences Tools & Services · South Korea · ISIN KR7039860002

Price

4,570.00 KRW

Market cap

172.94 bn KRW

P/E (2025)

109.44

P/S (2025)

4.54

Dividend yield

0.00 %

Net margin

4.14 %

Return on equity (ROE)

1.74 %

Return on assets (ROA)

1.61 %

NanoenTekInc financials

Fiscal year	2024	2025
Revenue	30.46 bn KRW	38.13 bn KRW
Gross profit	17.04 bn KRW	22.39 bn KRW
Operating income	620.87 m KRW	1.10 bn KRW
EBIT	3.73 bn KRW	1.11 bn KRW
Net income	3.59 bn KRW	1.58 bn KRW
Diluted EPS – continuing operations	111.67 KRW	41.76 KRW

Full history since 2007, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About NanoenTekInc

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescence cell counters and cell analyzers; brightfield cell counters; somatic cell counters; live-cell imaging system; and disposable hemocytometers. The company also provides digital healthcare services integrating artificial intelligence and big data technologies. The company was founded in 1987 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.